Assignee profile:

PENLAND FOUNDATION

City:

Beaumont, Texas

Country:

United States

Published Applications:

13

Last publication date:

2023-12-21

Patent Grants:

13

Last grant date:

2026-05-26

Top Inventors for applications by PENLAND FOUNDATION

These are the the leading inventors for applications assigned to PENLAND FOUNDATION:

Recent patent applications by PENLAND FOUNDATION

PENLAND FOUNDATION based in Beaumont, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-12-21 ✅ Patent 12,636,343 granted on 2026-05-26
US20230405083A1
Human necessities

TREATMENT METHODS USING BOTULINUM TOXINS

#2 | 2023-03-09 ✅ Patent 12,544,432 granted on 2026-02-10
US20230071295A1
Human necessities

TREATMENT OF ASTHMA USING BOTULINUM TOXIN

#3 | 2023-01-12 ✅ Patent 11,738,071 granted on 2023-08-29
US20230012181A1
Human necessities

TREATMENT OF ACUTE AND CHRONIC KIDNEY DISEASE

#4 | 2023-01-12 ✅ Patent 11,925,677 granted on 2024-03-12
US20230011705A1
Human necessities

Treatment of diabetes and chronic pancreatitis using botulinum toxin

#5 | 2023-01-12 ✅ Patent 12,280,096 granted on 2025-04-22
US20230009875A1
Human necessities

Treatments of cancer using nitrous oxide and botulinum toxin

#6 | 2022-12-01 ✅ Patent 12,251,431 granted on 2025-03-18
US20220378885A1
Human necessities

Botulinum toxin for use in treatment of autism spectrum disorders

#7 | 2022-11-17 ✅ Patent 12,599,625 granted on 2026-04-14
US20220362286A1
Human necessities

TREATMENT OF ARDS AND OTHER CONDITIONS CAUSED BY ACUTELY ELEVATED CYTOKINE LEVELS AND POST ARDS CHRONIC CYTOKINE PRODUCTION USING INHALED ANESTHETICS

#8 | 2022-04-21 ✅ Patent 11,439,694 granted on 2022-09-13
US20220118066A1
Human necessities

Botulinum toxin for use in treatment of autism spectrum disorders

#9 | 2021-09-30 ✅ Patent 11,744,881 granted on 2023-09-05
US20210299231A1
Human necessities

Treatment of amyotrophic lateral sclerosis using botulinum toxin

#10 | 2021-07-01 ✅ Patent 11,883,473 granted on 2024-01-30
US20210196803A1
Human necessities

Treatment of dyslexia using botulinum toxin

#11 | 2021-06-24 ✅ Patent 11,241,479 granted on 2022-02-08
US20210187063A1
Human necessities

Treatment methods using botulinum toxins

#12 | 2020-08-18 ✅ Patent 10,744,182 granted on 2020-08-18
US16657950
Human necessities

Treatment of narcotics tolerance using botulinum toxins

#13 | 2020-07-28 ✅ Patent 10,722,552 granted on 2020-07-28
US16657933
Human necessities

Treatment of autism using botulinum toxins

Also check out PENLAND FOUNDATION's (Beaumont, United States) applicant profile with 17 patent applications submitted.

AssigneeID:

351915 ⎘